NRX-252114 is a potent enhancer of the interaction between β-catenin, and its cognate E3 ligase, SCF. NRX-252114 enhances the binding of pSer33/S37A β-catenin peptide for β-TrCP with an EC 50 of 6.5 nM and a K d of 0.4 nM. NRX-252114 induces mutant β-catenin degradation.
NRX-252114 (20 μM) 增强 pSer33/S37A β-连环蛋白肽与 β-TrCP 的结合,协同作用超过 1500 倍。NRX-252114 (0-25 μM) 增加 pSer33/S37A β-连环蛋白肽的泛素化,形成长泛素链。NRX-252114 (0-25 μM) 增强 S33E/S37A β-连环蛋白以及未磷酸化的 Ser33/S37A β-连环蛋白肽的泛素化。NRX-252114 (20 μM,6 小时) 在转染的 HEK293T 细胞中产生稳健的 S33E/S37A β-连环蛋白: β-TrCP 相互作用。 has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Kyle R Simonetta, et al. Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction. Nat Commun. 2019 Mar 29;10(1):1402.
溶解度数据
In Vitro: DMSO : 100 mg/mL (195.96 mM; Need ultrasonic)配制储备液